| Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report JF Arboleda-Velasquez, F Lopera, M O’Hare, S Delgado-Tirado, C Marino, ... Nature medicine 25 (11), 1680-1683, 2019 | 423 | 2019 |
| Tau positron-emission tomography in former national football league players RA Stern, CH Adler, K Chen, M Navitsky, J Luo, DW Dodick, ML Alosco, ... New England journal of medicine 380 (18), 1716-1725, 2019 | 199 | 2019 |
| Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia MN Sabbagh, K Chen, J Rogers, AS Fleisher, C Liebsack, D Bandy, ... Alzheimer's & Dementia 11 (8), 994-1004, 2015 | 69 | 2015 |
| AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction F Gao, H Yoon, Y Xu, D Goradia, J Luo, T Wu, Y Su, ... NeuroImage: Clinical 27, 102290, 2020 | 54 | 2020 |
| Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial S Rios‐Romenets, F Lopera, KM Sink, N Hu, Q Lian, H Guthrie, J Smith, ... Alzheimer's & Dementia 16 (7), 1023-1030, 2020 | 16 | 2020 |
| Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia DA Weidman, E Zamrini, MN Sabbagh, S Jacobson, A Burke, C Belden, ... Neurocase 23 (1), 41-51, 2017 | 13 | 2017 |
| Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer's disease carriers and non‐carriers: baseline findings from the API ADAD Colombia Trial C Vila‐Castelar, PN Tariot, KM Sink, D Clayton, JB Langbaum, ... Alzheimer's & Dementia 18 (11), 2272-2282, 2022 | 11 | 2022 |
| Deep residual inception encoder‐decoder network for amyloid PET harmonization J Shah, F Gao, B Li, V Ghisays, J Luo, Y Chen, W Lee, Y Zhou, ... Alzheimer's & Dementia 18 (12), 2448-2457, 2022 | 10 | 2022 |
| PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers V Ghisays, F Lopera, DD Goradia, HD Protas, MH Malek-Ahmadi, Y Chen, ... NeuroImage: Clinical 31, 102749, 2021 | 9 | 2021 |
| Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired … M Malek-Ahmadi, Y Su, V Ghisays, J Luo, V Devadas, Y Chen, W Lee, ... Alzheimer's Research & Therapy 15 (1), 74, 2023 | 7 | 2023 |
| A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial EM Reiman, JJ Pruzin, S Rios‐Romenets, C Brown, M Giraldo, ... Alzheimer's & Dementia 19 (5), 1938-1946, 2023 | 3 | 2023 |
| P4–068: Pre‐symptomatic functional brain changes in PS1 E280A mutation carriers compared with other biomarkers: Pilot data from the Alzheimer's Prevention Initiative Biomarker … A Fleisher, K Chen, Y Quiroz, L Jakimovich, M Gutierrez, J Langbaum, ... Alzheimer's & Dementia 9, P729-P729, 2013 | 3 | 2013 |
| Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project Y Su, H Protas, J Luo, K Chen, ML Alosco, CH Adler, LJ Balcer, C Bernick, ... Alzheimer's & Dementia 20 (3), 1827-1838, 2024 | 1 | 2024 |
| MRI signatures of Brain Age in the Alzheimer’s disease continuum J Shah, V Ghisays, Y Chen, J Luo, B Li, EM Reiman, K Chen, T Wu, Y Su Alzheimer's & Dementia 18, e061942, 2022 | 1 | 2022 |
| CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes … V Ghisays, WJ Jansen, Y Chen, HD Protas, MH Malek‐Ahmadi, J Luo, ... Alzheimer's & Dementia 17, e057242, 2021 | 1 | 2021 |
| Sex differences in neurodegeneration and memory performance in preclinical autosomal dominant Alzheimer’s disease: Baseline findings from the API ADAD trial: Intersections of … C Vila‐Castelar, PN Tariot, KM Sink, D Clayton, JB Langbaum, ... Alzheimer's & Dementia 16, e041225, 2020 | 1 | 2020 |
| [IC‐P‐041]: SAMPLE SIZES FOR 24‐MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID‐POSITIVE ADULTS EM Reiman, X Kuang, J Luo, Y Chen, P Thiyyagura, R Bauer III, W Lee, ... Alzheimer's & Dementia 13 (7S_Part_1), P36-P37, 2017 | 1 | 2017 |
| P1‐135: Ovarian hormone loss induced decline in glucose availability and shift to alternative substrates in brain F Ding, J Luo, J Yao, Z Mao, S Chen, K Chen, E Reiman, R Brinton Alzheimer's & Dementia 8 (4S_Part_4), P153-P153, 2012 | 1 | 2012 |
| Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions‐of‐interest and machine learning techniques: An alternative to the … K Chen, V Ghisays, J Luo, Y Chen, W Lee, T Wu, EM Reiman, Y Su Alzheimer's & Dementia, 2024 | | 2024 |
| Florbetapir PET Uptake in White Matter in Aging and Alzheimer’s Disease V Bhargava, J Luo, Y Chen, V Ghisays, MH Malek‐Ahmadi, J Sohankar, ... Alzheimer's & Dementia 19, e079283, 2023 | | 2023 |
